Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IgG2a Rat anti-Mouse, Brilliant Violet 605, Clone: R19-15, BD

Catalog No. BDB564024 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB564024 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB564024 Supplier BD Biosciences Supplier No. 564024
Add to Cart
Add to Cart

Rat Monoclonal Antibody

The R19-15 antibody recognizes an epitope in the CH3 domain of mouse IgG2a, with strong reactivity to the Igh-I[a] allotype and weaker reactivity to Igh-I[b]. It does not react with other Ig isotypes. Molecular genetic analyses suggest that the Igh-I[b] allele, which encodes is derived from a locus found in several wild mouse subspecies, but not domestic mice, which encodes the IgG2c isotype.

TRUSTED_SUSTAINABILITY

Specifications

Antigen IgG2a
Applications Flow Cytometry
Classification Monoclonal
Clone R19-15
Concentration 0.2mg/mL
Conjugate Brilliant Violet 605
Formulation Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Host Species Rat
Immunogen Pooled BALB/c and C57BL/6 mouse Ig
Purification Method Affinity Purified
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Secondary
Target Species Mouse
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.